Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on... When Research Is Groundbreaking, Revolutionary, & Game-changing—and When It's Not

  Sarah DiGiulio

• Free

  BOOKS: ‘The Compatibility Gene,’ by Daniel M. Davis

  Robert C. Young MD

• Free

  FDA Approval for New Targeted NSCLC Drug
• Free

  FDA Approves Darzalex for Previously Treated Multiple Myeloma
• Free

  FDA Breakthrough Therapy Designation to Avelumab for Merkel Cell Carcinoma
• Free

  Indications that Radiation Can Enhance Immunotherapy's Effects in Metastatic Melanoma

  Robert H. Carlson

• Free

  John Leonard Previews Upcoming Strategies for Treating Progressive Indolent B-Cell NHL

  Sarah DiGiulio

• Free

  Large, Prospective Study Shows Less Toxicity with IMRT in Locally Advanced NSCLC

  Robert H. Carlson

• Free

  Lung Cancer: Receipt of Curative Surgery Found to Vary from State to State
• Free

  MUSINGS OF A CANCER DOCTOR: In Our Stars

  George W. Sledge MD

• Free

  Protocol Alert
• Free

  Shop Talk
• Free

  View from the Other Side of the Stethoscope: Holiday Hopes and Wishes

  Wendy S. Harpham MD

• Free

  VOICES: MD Anderson's EDGE Preclinical Solutions Program—Aiming to Overcome Challenges of Preclinical Research for Breast Cancer Early Drug Development

  Jangsoon Lee PhD,Bora Lim MD,Naoto T. Ueno MD, PhD, FACP

• Buy

  Award-Winning Study of High-Risk Head & Neck Patients Documents Key Role for APNs in Radiation Oncology

  Robert H. Carlson

• Buy

  Documented: Conversations about Prognosis are Helpful to Patients with Advanced Cancer

  Christine Kilgore

• Buy

  ECRI/NCI Meeting: Challenges in the Rapidly Changing Cancer Care Delivery System

  Peggy Eastman

• Buy

  How We Treat Patients with Relapsed/Refractory AML

  Courtney D. Dinardo MD, MSCE,Farhad Ravandi MD

• Buy

  New Microsurgical Procedure Lowers Risk of Secondary Lymphedema in Pilot Study

  Meeri Kim PhD

• Buy

  Payment Reform: ‘Nothing is Easy’

  Lola Butcher